FDA Inspection 636203 — Fougera Pharmaceuticals LLC

Fougera Pharmaceuticals LLC — FEI 2432435

The FDA completed an inspection of Fougera Pharmaceuticals LLC on Jan 12, 2010 in Melville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 16 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 12, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Compliance: Devices
Location
Melville, NY (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
126121 CFR 211.68(a)Written calibration / inspection records not kept
135821 CFR 211.100(b)SOPs not followed / documented
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143521 CFR 211.42(c)(10)(v)Cleaning System
145121 CFR 211.113(b)Procedures for sterile drug products
180921 CFR 211.160(a)Following/documenting laboratory controls
202821 CFR 211.192Extent of discrepancy, failure investigations
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
358521 CFR 211.110(a)Control procedures to monitor and validate performance
361321 CFR 211.160(b)(4)Establishment of calibration procedures
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
441221 CFR 211.194(a)(7)Signatures and dates--person who performs test
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.